Cas:219965-90-9 (2R)-2-acetamido-3-(2,3,4-trihydroxybutylsulfanyl)propanoic acid manufacturer & supplier

We serve Chemical Name:(2R)-2-acetamido-3-(2,3,4-trihydroxybutylsulfanyl)propanoic acid CAS:219965-90-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2R)-2-acetamido-3-(2,3,4-trihydroxybutylsulfanyl)propanoic acid

Chemical Name:(2R)-2-acetamido-3-(2,3,4-trihydroxybutylsulfanyl)propanoic acid
CAS.NO:219965-90-9
Synonyms:N-Acetyl-S-(2,3,4-trihydroxybutyl)-L-cysteine;S-(2,3,4-Trihydroxybutyl)mercapturic Acid;S-(2,3,4-Trihydroxybutyl)mercapturic Acid (Mixture of Diatstereomers);L-Cysteine,N-acetyl-S-(2,3,4-trihydroxybutyl)
Molecular Formula:C9H17NO6S
Molecular Weight:267.29900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:689.927ºC at 760 mmHg
Density:1.443g/cm3
Index of Refraction:1.577
PSA:152.39000
Exact Mass:267.07800
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-Acetyl-S-(2,3,4-trihydroxybutyl)-L-cysteine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Cysteine,N-acetyl-S-(2,3,4-trihydroxybutyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,S-(2,3,4-Trihydroxybutyl)mercapturic Acid Use and application,N-Acetyl-S-(2,3,4-trihydroxybutyl)-L-cysteine technical grade,usp/ep/jp grade.


Related News: The FDA said its decision allows for the J&J doses to be used in the United States or exported. T (2R)-2-acetamido-3-(2,3,4-trihydroxybutylsulfanyl)propanoic acid manufacturer The FDA said its decision allows for the J&J doses to be used in the United States or exported. T (2R)-2-acetamido-3-(2,3,4-trihydroxybutylsulfanyl)propanoic acid supplier The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. (2R)-2-acetamido-3-(2,3,4-trihydroxybutylsulfanyl)propanoic acid vendor The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter. (2R)-2-acetamido-3-(2,3,4-trihydroxybutylsulfanyl)propanoic acid factory The FDA said its decision allows for the J&J doses to be used in the United States or exported. T